Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

14.40
BATS BZX Real-Time Price
As of 3:45pm ET
 -0.35 / -2.37%
Today’s Change
5.50
Today|||52-Week Range
16.00
+34.58%
Year-to-Date
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close14.75
Today’s open14.90
Day’s range14.40 - 15.00
Volume3,005
Average volume (3 months)255,297
Market cap$373.0M
Data as of 3:45pm ET, 12/18/2017

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)-25.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.19%
P/E ratioNM
Price/Sales182.95
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
MDGLMadrigal Pharmaceuti...+1.50+1.82%
OVIDOvid Therapeutics In...-0.42-4.32%
ZYMEZymeworks Inc-0.12-1.51%
CMRXChimerix Inc0.000.00%
Data as of 3:47pm ET, 12/18/2017

Financials

Next reporting dateMarch 16, 2018
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$1.0M
Annual profit (last year)-$38.3M
Net profit margin-3,678.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts